bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
Dhurvas Chandrasekaran Dinesh1#, Dominika Chalupska1#, Jan Silhan1, Vaclav Veverka1,2*, Evzen
Boura1,*
1Institute

of Organic Chemistry and Biochemistry AS CR, v.v.i., Flemingovo nam. 2., 166 10 Prague 6, Czech Republic

2Department
# co-first

of Cell Biology, Faculty of Science, Charles University, Vinicna 7, 128 10 Prague 2, Czech Republic

author

*correspondence to veverka@uochb.cas.cz or boura@uochb.cas.cz

Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the Coronavirus
disease 2019 (COVID-19) which is currently negatively affecting the population and disrupting the global
economy. SARS-CoV-2 belongs to the +RNA virus family that utilize single-stranded positive-sense RNA
molecules as genomes. SARS-CoV-2, like other coronaviruses, has an unusually large genome for a +RNA
virus that encodes four structural proteins â€“ the matrix (M), small envelope (E), spike (S) and nucleocapsid
phosphoprotein (N) - and sixteen nonstructural proteins (nsp1-16) that together ensure replication of the
virus in the host cell. The nucleocapsid phosphoprotein N is essential for linking the viral genome to the
viral membrane. Its N-terminal RNA binding domain (N-NTD) captures the RNA genome while the Cterminal domain anchors the ribonucleoprotein complex to the viral membrane via its interaction with the
M protein. Here, we characterized the structure of the N-NTD and its interaction with RNA using NMR
spectroscopy. We observed a positively charged canyon on the surface of the N-NTD lined with arginine
residues suggesting a putative RNA binding site. Next, we performed an NMR titration experiment using
an RNA duplex. The observed changes in positions of signals in the N-NTD NMR spectra allowed us to
construct a model of the N-NTD in complex with RNA.

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

Introduction
Positive-sense, single-stranded RNA viruses pose a global threat to human health as documented
by the recent Zika virus outbreak and, more importantly, by the current COVID-19 pandemic caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of the Coronaviridae family. SARS-CoV2 earned its name due to the similarity of its genome to that of the SARS virus. Another deadly virus, the
MERS (Middle East respiratory syndrome) virus is also a member of the Coronaviridae family,
demonstrating how dangerous its members can be to humans. However, the recent COVID-19 pandemic is
noteworthy. It is the most dangerous coronavirus to date, causing thousands of deaths, overwhelming the
global health care system capacity, disrupting our everyday lives and causing enormous economic damage.
It also reminds us of the vulnerability of our civilization to pathogens and highlights the importance of
antiviral research.
Coronaviruses have the largest known genomes (up to 32 kb) among +RNA viruses, and they
encode four structural and sixteen non-structural proteins. The non-structural proteins carry all of the
enzymatic activities important for the viral replication, mostly associated with RNA replication. The
genome SARS-CoV-2 also encodes an RNA-dependent RNA-polymerase complex (nsp7, nsp8 and nsp12),
RNA capping machinery (nsp10, nsp13, nsp14 and 16) and additional enzymes such as proteases (the nsp3
PLpro and the nsp5 3CLpro) which cleave viral polyproteins and/or impede innate immunity (1). The four
structural proteins together with the viral +RNA genome and the envelope constitute the virion. The matrix
(M), small envelope (E), and spike (S) proteins are embedded within the lipid envelope. The fourth
structural protein, the nucleocapsid phosphoprotein (N), physically links the envelope to the +RNA
genome. It consists of an N-terminal (NTD) and a C-terminal (CTD) domain (Figure 1). Both domains are
capable of RNA binding. In addition, the CTD serves as a dimerization domain and binds the matrix protein
forming the physical link between the+ RNA genome and the envelope. The SARS N protein has also been
shown to modulate the host intracellular machinery and plays regulatory roles during the viral life cycle
(2). In light of the genomic similarities between SARS-CoV and SARS-CoV-2, it is reasonable to expect
the N protein to function in a similar way.
All the SARS-CoV-2 proteins are potential drug targets (3) and a detailed understanding of their
functions is therefore of utmost importance. An experimental treatment using remdesivir, which has been
tested in several countries strongly affected by COVID-19, targets the RNA-dependent RNA-polymerase
nsp12, as does favipiravir (also known as T-705), which has been approved for clinical use in Japan and
China. Both remdesivir and favipiravir are nucleotide analogs. However, unlike most RNA viruses, SARS-

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

CoV-2 encodes an exonuclease (a second enzymatic activity of the RNA capping factor nsp14) presumably
capable of repairing mismatches in newly synthesized double-stranded RNA. Additional antiviral
compounds might be necessary to simultaneously target several viral proteins and create a trap that the virus
cannot escape by mutation. In any case, drugs targeting proteins other than the RNA polymerase are
urgently needed. In this study, we have analyzed in detail the structure of the N protein NTD (N-NTD) and
its interaction with RNA using protein NMR. Based on this data we generated a model of the N-NTD and
its complex with RNA that illustrates how the N protein recognizes RNA and provides a basis for rational
drug design.
Results
Here, we report the NMR structure of the SARS-CoV-2 nucleocapsid phosphoprotein N-terminal RNA
binding domain N-NTD. The structure revealed an overall right hand-like fold composed of a Î²-sheet core
with an extended central loop. The core region adopts a five-stranded U-shaped right-handed antiparallel
Î²-sheet platform with the topology Î²4-Î²2-Î²3-Î²1-Î²5 flanked by two short Î±-helices (Î±1 occurs before the Î²2
strand and Î±2 after the Î²4 strand). A prominent feature of the structure is a large protruding loop between
Î²2-Î²3 that forms a long basic Î²-hairpin (Î²2â€™ and Î²3â€™) (Figure 2). This long Î²-hairpin is reminiscent of a
finger and composed mostly of basic amino acids residues, and we therefore refer to it as a basic finger
(Figure 2). This basic finger extends from the Î²-core structure that we refer to as a palm. Analysis of the
electrostatic potential of the N-NTD revealed a highly positively charged cleft between the basic finger and
the palm creating a putative RNA binding site in the hinge/junction region between the palm and basic
finger. Our NMR analysis is consistent with recent X-ray analysis (PDB IDs: 6M3M and 6VYO). In
addition, the NMR structure revealed that the basic finger is highly flexible (Figure 2A) whereas in the
crystal structures it is locked in one place by crystal lattice contacts.
The structure of the N-NTD suggests a putative RNA binding site. Intrigued, we aimed to obtain an
experimental model of the N-NTD in a complex with RNA. We performed an NMR-based titration
experiment using a short double-stranded RNA (5'-CACUGAC-3' and 5'-GUCAGUG-3'). Basically, we
were adding isotopically unlabeled RNA to the

15

N/13C labeled protein and we followed changes in

positions of assigned signals in NMR spectra (Figure 3) to reveal the molecular interface of the NNTD:RNA complex. Overlay of the 2D 15N/1H HSQC and 2D 13C/1H HSQC spectra of a free and RNA
bound N-NTD revealed residues that were significantly perturbed by RNA binding. All these significantly
affected residues (A50, T57, H59, R92, I94, S105, R107, R149, Y172) are located in the basic finger or
close to the junction between the basic finger and the palm as expected based on the analysis of the
electrostatic potential.

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

We next used the experimental data to build an atomic model of the protein:RNA complex. We used the
HADDOCK protocol for NMR-restraint driven docking simulations (4). As a starting conformation of the
RNA we chose a short double helix based on the published crystal structure of a short RNA duplex (5). A
detailed analysis of the chemical shift perturbations (CSP) mapped onto the solution structure of N-NTD
provided a set of â€˜activeâ€™ solvent-accessible residues on N-NTD that were expanded to surrounding
â€˜passiveâ€™ residues. The selection criteria for active residues were that their CSP values were more than one
standard deviation from the average value (0.05 ppm) calculated for the entire set of CSPs and that their
accessibility to solvent was more than 20% (6). Restraints for the RNA molecule were kept ambiguous to
avoid potential bias. A standard docking protocol yielded a set of water-refined conformations for the
protein:RNA complex that were clustered into several distinct classes. As expected, the RNA duplex
molecule was bound in the positively charged cleft in all clusters. The most populated cluster also contained
the fewest violations of experimental restraints and was therefore selected as a representative conformation
for the N-NTD: RNA complex.
The structure revealed an RNA duplex bound to the positively charged canyon located between the basic
finger and the palm of the N-NTD. A notable feature of the binding interface is its electrostatic potential. It
is highly positive with several arginine residues (R92, R107, R149) that directly contact the RNA. Our
model also predicts several hydrophobic interactions, such as one involving the side-chains of residues I94
and L104, which also contribute to RNA binding. Taken together our data provide a molecular snapshot of
RNA recognition by the coronaviral N protein and suggest a hot spot located at the interface of the basic
finger and the palm as a suitable target for targeting by small molecules.
Discussion
Effective drugs are urgently needed to combat the COVID-19 disease. Most patients are not given any drug
and the treatment relies on curing the symptoms. The most promising drug is remdesivir, a nucleotide
analog that targets the viral RNA-dependent RNA-polymerase (RdRp). Viral polymerases are certainly
good targets for antiviral compounds as these enzymes are absolutely vital for any +RNA virus. However,
every viral protein is a potential target for antiviral compounds and an effective treatment may require
several active compounds, each targeting a different protein at the same time. This approach, known as
HAART (highly active antiretroviral therapy), has proven effective in the case of HIV, which is another
virus with an RNA genome. In this study, we structurally characterized the N protein, a structural protein
that is essential for assembly of the virion. We obtained an atomic model of the N protein N-terminal
domain in an unliganded form and in complex with an RNA duplex. The structure revealed a right hand
fold featuring a prominent basic finger protruding from the palm. Analysis of its electrostatic potential

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

(Figure 2C) revealed highly positively charged canyon that is situated in the interface between the basic
finger and the palm subdomain and constitutes a putative RNA binding site. We performed an NMR
titration experiment to obtain experimental proof of the RNA binding site. An overlay of the 15N/13C labeled
protein NMR spectrum in the absence of ligand and in complex with RNA revealed amino acid residues
with large chemical shifts upon the addition of RNA (Figure 3). Not surprisingly, all these residues are
located in or in close proximity to the basic canyon, confirming the canyon as the RNA binding site. To
illustrate how the coronaviral N-NTD recognizes RNA we built an atomic model of the N-NTD:RNA
complex using the NMR titration data as a restraint for computer simulations in HADDOCK. The model
reveals a hotspot on the surface of the N-NTD between the finger and palm subdomains that is essential for
RNA binding and suggests this site as an ideal place for targeting by small molecules.
Materials and Methods
Protein expression, and purification â€“ N-terminal domain of the SARS CoV-2 N protein (N-NTD, residues
44-180) was expressed as a fusion protein with 6xHis tag followed by cleavage site for TEV protease on
its N-terminus. Escherichia coli BL21(DE3) expressing the protein were grown in minimal media
containing 15NH4Cl and [U-13C]glucose. The culture was lysed by sonication in lysis buffer (50 mM Tris
pH 8.0, 500 mM NaCl, 20 mM imidazole, 10% glycerol, 3mM Î²-mercaptoethanol) and the lysate was
cleared by centrifugation. His-tagged protein was purified from the supernatant by affinity chromatography
on a Nickel-NTA column (Machery-Nagel) according to manufactur's instruction, the 6x His tag was cut
off by the TEV protease and the protein was further purified by size-exclusion chromatography on a
Superdex 75 HiLoad 26/60 column (GE Healthcare) in SEC buffer (20 mM Na2HPO4, 50 mM NaCl, 0.01%
NaN3, pH 5.5). Purity of the protein was checked using SDS-PAGE. Protein was concentrated to 1.19 mM
and used for NMR experiments. For further NMR measurements of binding RNA, the N-NTD was diluted
to 300 Î¼M and flash frozen in liquid nitrogen and stored in -80Â°C until needed.
To examine the RNA binding mode of the N-NTD we used a commercially available 7mer RNA duplex
that was prepared by annealing of RNA oligonucleotides 5'-CACUGAC-3' and 5'-GUCAGUG-3' (Sigma).
The RNA oligonucleotides were mixed in a molar ratio 1:1 at the final concetration 200 Î¼M of each
oligonucleotide and water supplemented with 50 mM NaCl. The mixture was incubated at 60Â°C for 15 min
and then cooled slowly at 26Â°C. For RNA titration, annealed RNA was added to 50 Î¼M protein in molar
ratios 1:0.3125, 1:0.625, 1:1 and 1:2.

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

NMR spectroscopy - NMR spectra were acquired at 25 Â°C on an 850 MHz Bruker Avance spectrometer,
equipped with a triple-resonance (15N/13C/1H) cryoprobe. The sample volume was either 0.16 or 0.35 mL,
in SEC buffer, 5% D2O/90-95% H2O. A series of double- and triple-resonance spectra (7, 8) were recorded
to obtain sequence-specific resonance assignment. We used I-PINE assignment tool (9) implemented in
NMRFAM-SPARKY (10) for initial automatic assignment. 1H-1H distance restraints were derived from
3D 15N/1H NOESY-HSQC and 13C/1H NOESY-HMQC, which were acquired using a NOE mixing time of
100 ms.
The structural calculation was carried out in Cyana (11) using NOESY data in combination with backbone
torsion angle restraints, generated from assigned chemical shifts using the program TALOS+ (12). First,
the combined automated NOE assignment and structure determination protocol (CANDID) was used for
automatic NOE cross-peak assignment. Subsequently, five cycles of simulated annealing combined with
redundant dihedral angle restraints were used to calculate a set of converged structures with no significant
restraint violations (distance and van der Waals violations <0.5Ã… and dihedral angle constraint violations
<5Â°). The 40 structures with the least restraint violations were further refined in explicit solvent using the
YASARA software with the YASARA forcefield(13) and subjected to further analysis using the Protein
Structure Validation Software suite (www.nesg.org). The statistics for the resulting structure is summarized
in Table 1. The structures, NMR restraints and resonance assignments were deposited in the Protein Data
Bank (PDB, accession code: 6YI3) and BMRB (accession code: 34511).
To follow changes in the chemical shifts of a protein upon RNA binding, we calculated chemical shift
perturbations (CSPs). The CSP of each assigned resonance in the 2D 15N/1H HSQC spectra of the protein
in the free state is calculated as the geometrical distance in ppm to the peak in the 2D 15N/1H HSQC spectra
acquired under different conditions using the formula: Î”ð›¿ = âˆšÎ”ð›¿ð» 2 + (Î”ð›¿ð‘ âˆ™ ð›¼)2 , where ï¡ is a weighing
factor of 0.2 used to account for differences in the proton and nitrogen spectral widths.(14)
Molecular docking - The structure for the N-NTD in complex with the 7mer RNA duplex was calculated
using HADDOCK (4). The RNA homology model was prepared by mutating the native 7mer RNA duplex
(PDB 4U37) (5) in Pymol (The PyMOL Molecular Graphics System, Version 2.0 SchrÃ¶dinger, LLC.) that
was subsequently subjected to an energy minimization in YASARA (13). For the actual docking, we used
a representative structure from the set of obtained structures and followed a standard protocol. As active
were selected those N-NTD residues with CSP > 0.05 ppm and at least 20% solvent accessibility (A50,
T57, H59, R92, I94, S105, R107, R149, A152 and Y172), while as passive were additionally selected
adjacent solvent exposed residues (T49, T54, L55, R88, A90, K102, L104, Y109, Y111, P151, A155, A156,
E174 and G175). On RNA side, all 14 nucleobases were defined as active for the experimentally driven

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

docking protocol. In addition, in total three regions within the N-NTD were defined as fully flexible
segments for the advanced stages of the docking calculation (the N-terminal G1-T9, the central loop I54M61 and the C-terminal S136-S140). The final set of 200 water-refined structures was clustered using a
Fraction of Common Contacts approach (15) with a default cut-off 0.75 and a minimal cluster size = 4. The
resulting structures were sorted into 7 clusters and the most populated cluster (n = 30) that also exhibited
the lowest interaction energy was selected for detailed analysis.
Author Contributions
DCD, DC, JS and VV performed experiments, VV interpreted the NMR data and built the final model. VV and EB
designed and supervised the project. VV and EB wrote the manuscript, all authors commented on the manuscript.
Acknowledgement
The work was supported from European Regional Development Fund; OP RDE; Project: "Chemical biology for
drugging undruggable targets (ChemBioDrug)" (No. CZ.02.1.01/0.0/0.0/16_019/0000729). The Academy of Sciences
of the Czech Republic (RVO: 61388963) is also acknowledged. We are grateful to Edward Curtis for critical reading
of the manuscript.
Accession codes

The NMR restraints, resonance assignments and the structure were deposited in the PDB under accession
code 6YI3 and in the BMRB database under accession code 34511).
Figure legends
Figure 1 â€“ SARS-CoV-2 virion and model of structural proteins. (A) Enlarged view of the viral
membrane showing the four structural proteins: spike â€“ S, membrane â€“ M, envelope â€“ E, and nucleocapsid
phosphoprotein â€“ N, along with viral membrane and the RNA genome. (B) Transmission electron
microscopic image of a single SARS-CoV-2 viral particle (NIH, NIAID-RML). (C) Domain organization
of the full length N-protein. (D) Schematic organization of the N protein dimer formed through the CTD
domain (the N-NTD is shown in red and the N-CTD in lavender)
Figure 2 â€“ Solution structure of the SARS-CoV-2 N-NTD RNA binding domain (A) Backbone
representation of the 40 converged structures of N-NTD obtained by NMR spectroscopy. (B) Cartoon
representation of the lowest energy structure (structural elements are highlighted in color: Î±1-Î±2 helices
(yellow), Î²1-(Î²2â€™-Î²3â€™)-Î²5 (green), and loops (gray)) show the overall U-shaped antiparallel Î²-sheet platform
(the palm) and a protruding Î²-hairpin (the basic finger). (C) The N-NTD molecular surface electrostatic

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

potentials revealed a basic patch extended between the finger and the palm, with positively charged surface
shown in blue and negatively charged surface in red. (D) Topology diagram of the N-NTD.
Figure 3 â€“ NMR-based mapping and a model of the N-NTD:RNA complex. (A) Representative regions
from the 2D 15N/1H HSQC titration spectra illustrating effects of addition of the 7mer RNA duplex on
backbone and side-chain N-NTD amide signals (arginine side-chains are labeled with Îµ â€“ top left panel).
The 50 ÂµM 15N-labeled N-NTD protein construct was titrated with an increasing concentration of RNA.
(B) Chemical shift perturbations of N-NTD residues upon binding of an equimolar concentration of 7mer
RNA duplex. (C) The CSPs highlighted on as a red-color gradient on the ribbon representation of 40
converged structures of N-NTD. The majority of the perturbed residues form a large continuous patch from
R92 to Y172 on one side of the positively charged cleft and a smaller patch formed by A50 and R149 on
the opposite side of the cleft. The solvent exposed sidechains of the most perturbed residues are shown as
sticks. (D) N-NTD:RNA complex. The RNA duplex is shown as a cartoon structure over the electrostatic
surface of SARS-CoV-2 N-NTD and the interacting residues are highlighted as sticks.
Table 1- NMR Constraints and Statistics for the final set of structures.

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

Figure 1

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

Figure 2

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

Figure 3

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

Table 1

Non-redundant distance and angle constrains
Total number of NOE restraints
Short-range NOEs
Medium-range NOEs (1 < | i - j | < 5)
Long-range NOEs (| i - j | â‰¥ 5)
Torsion angles
Total number of restricting restraints
Total restricting restraints per restrained residue
Residual constraint violations
Distance violations per structure
0.1 â€“ 0.2 Ã…
0.2 â€“ 0.5 Ã…
> 0.5 Ã…
r.m.s. of distance violation per constraint
Maximum distance violation
Dihedral angle viol. per structure
1 â€“ 10 Â°
> 10 Â°
r.m.s. of dihedral violations per constraint
Maximum dihedral angle viol.
Ramachandran plot summary
Most favoured regions
Additionally allowed regions
Generously allowed regions
Disallowed regions
r.m.s.d. to the mean structure
All backbone atoms
All heavy atoms
PDB entry
BMRB accession code
1
Residues with sum of phi and psi order parameters > 1.8

2405
1281
252
872
176
2581
21.5

2.8
0.3
0
0.01 Ã…
0.29 Ã…
12.9
2
0.49Â°
5.9Â°
87.0 %
11.9 %
0.8 %
0.3 %
all/ordered1
2.0/1.1 Ã…
2.1/1.5 Ã…
6YI3
34511

bioRxiv preprint doi: https://doi.org/10.1101/2020.04.02.022194; this version posted April 5, 2020. The copyright holder for this preprint (which
was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC-ND 4.0 International license.

References
1.
2.
3.
4.

5.

6.

7.

8.
9.
10.
11.

12.
13.
14.

15.

Snijder EJ, Decroly E, & Ziebuhr J (2016) The Nonstructural Proteins Directing Coronavirus RNA
Synthesis and Processing. Advances in virus research 96:59-126.
Chang CK, Hou MH, Chang CF, Hsiao CD, & Huang TH (2014) The SARS coronavirus nucleocapsid
protein--forms and functions. Antiviral research 103:39-50.
Gordon DE, et al. (2020) A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug
Targets and Potential Drug-Repurposing. BioRxiv.
Dominguez C, Boelens R, & Bonvin AM (2003) HADDOCK: a protein-protein docking approach
based on biochemical or biophysical information. Journal of the American Chemical Society
125(7):1731-1737.
Sheng J, Larsen A, Heuberger BD, Blain JC, & Szostak JW (2014) Crystal structure studies of RNA
duplexes containing s(2)U:A and s(2)U:U base pairs. Journal of the American Chemical Society
136(39):13916-13924.
Wilkinson IC, et al. (2009) High resolution NMR-based model for the structure of a scFv-IL-1beta
complex: potential for NMR as a key tool in therapeutic antibody design and development. The
Journal of biological chemistry 284(46):31928-31935.
Renshaw PS, et al. (2004) Sequence-specific assignment and secondary structure determination
of the 195-residue complex formed by the Mycobacterium tuberculosis proteins CFP-10 and
ESAT-6. Journal of biomolecular NMR 30(2):225-226.
Veverka V, et al. (2006) NMR assignment of the mTOR domain responsible for rapamycin
binding. Journal of biomolecular NMR 36 Suppl 1:3.
Lee W, et al. (2019) I-PINE web server: an integrative probabilistic NMR assignment system for
proteins. Journal of biomolecular NMR 73(5):213-222.
Lee W, Tonelli M, & Markley JL (2015) NMRFAM-SPARKY: enhanced software for biomolecular
NMR spectroscopy. Bioinformatics 31(8):1325-1327.
Herrmann T, Guntert P, & Wuthrich K (2002) Protein NMR structure determination with
automated NOE assignment using the new software CANDID and the torsion angle dynamics
algorithm DYANA. Journal of molecular biology 319(1):209-227.
Shen Y, Delaglio F, Cornilescu G, & Bax A (2009) TALOS+: a hybrid method for predicting protein
backbone torsion angles from NMR chemical shifts. Journal of biomolecular NMR 44(4):213-223.
Harjes E, et al. (2006) GTP-Ras disrupts the intramolecular complex of C1 and RA domains of
Nore1. Structure 14(5):881-888.
Veverka V, et al. (2008) Structural characterization of the interaction of mTOR with phosphatidic
acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in
small molecule-mediated regulation of mTOR. Oncogene 27(5):585-595.
Rodrigues JP, et al. (2012) Clustering biomolecular complexes by residue contacts similarity.
Proteins 80(7):1810-1817.

